Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibo Tang

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Stem Cell Research|September 4, 2024
Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSCXihao Sun, Shengru Mao, Yuqin Liang, et al.
Stem Cell Research|May 30, 2019
Establishment of CSUASOi001-A, a non-integrated induced pluripotent stem cell line from urine-derived cells of a Chinese patient carrying RS1 gene mutationXin Yan, Yonglong Guo, Juan Chen, et al.
Retina (Philadelphia, Pa.)|August 9, 2014
Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edemaQingyun Liu, Yijun Hu, Honghua Yu, et al.
Journal of Molecular Histology|May 3, 2013
The influence of high glucose on the Cip/Kip family expression profiles in HRECsJingyi Tian, Hongjie Ma, Yan Luo, et al.
Experimental Eye Research|July 5, 2022
Suppression of EZH2 inhibits TGF-β1-induced EMT in human retinal pigment epithelial cellsYu Peng, Kai Liao, Feng Tan, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 12, 2014
EXTEND II: an open-label phase III multicentre study to evaluate efficacy and safety of ranibizumab in Chinese patients with subfoveal choroidal neovascularization secondary to age-related macular degenerationJialiang Zhao, Xiaoxin Li, Shibo Tang, et al.
Biochemical and Biophysical Research Communications|December 8, 2010
Mitochondria-targeted antioxidant peptide SS31 attenuates high glucose-induced injury on human retinal endothelial cellsJianqiao Li, Xiaoyun Chen, Wei Xiao, et al.
Acta Biomaterialia|May 11, 2019
The Construction of Retinal Pigment Epithelium Sheets with Enhanced Characteristics and Cilium Assembly Using iPS Conditioned Medium and Small Incision Lenticule Extraction Derived LenticulesJianing Gu, Yini Wang, Zekai Cui, et al.
Stem Cell Research|April 27, 2020
Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patientYalan Zhou, Yutong Jing, Shengru Mao, et al.
Stem Cell Research|November 6, 2020
Establishment of non-integrate induced pluripotent stem cell line CSUASOi006-A, from urine-derived cells of a PRPF8-related dominant retinitis pigmentosa patientYalan Zhou, Zekai Cui, Yutong Jing, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Stem Cell Research|September 4, 2024
Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSCXihao Sun, Shengru Mao, Yuqin Liang, et al.
Stem Cell Research|May 30, 2019
Establishment of CSUASOi001-A, a non-integrated induced pluripotent stem cell line from urine-derived cells of a Chinese patient carrying RS1 gene mutationXin Yan, Yonglong Guo, Juan Chen, et al.
Retina (Philadelphia, Pa.)|August 9, 2014
Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edemaQingyun Liu, Yijun Hu, Honghua Yu, et al.
Journal of Molecular Histology|May 3, 2013
The influence of high glucose on the Cip/Kip family expression profiles in HRECsJingyi Tian, Hongjie Ma, Yan Luo, et al.
Experimental Eye Research|July 5, 2022
Suppression of EZH2 inhibits TGF-β1-induced EMT in human retinal pigment epithelial cellsYu Peng, Kai Liao, Feng Tan, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 12, 2014
EXTEND II: an open-label phase III multicentre study to evaluate efficacy and safety of ranibizumab in Chinese patients with subfoveal choroidal neovascularization secondary to age-related macular degenerationJialiang Zhao, Xiaoxin Li, Shibo Tang, et al.
Biochemical and Biophysical Research Communications|December 8, 2010
Mitochondria-targeted antioxidant peptide SS31 attenuates high glucose-induced injury on human retinal endothelial cellsJianqiao Li, Xiaoyun Chen, Wei Xiao, et al.
Acta Biomaterialia|May 11, 2019
The Construction of Retinal Pigment Epithelium Sheets with Enhanced Characteristics and Cilium Assembly Using iPS Conditioned Medium and Small Incision Lenticule Extraction Derived LenticulesJianing Gu, Yini Wang, Zekai Cui, et al.
Stem Cell Research|April 27, 2020
Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patientYalan Zhou, Yutong Jing, Shengru Mao, et al.
Stem Cell Research|November 6, 2020
Establishment of non-integrate induced pluripotent stem cell line CSUASOi006-A, from urine-derived cells of a PRPF8-related dominant retinitis pigmentosa patientYalan Zhou, Zekai Cui, Yutong Jing, et al.
Pageof 15